Larimar Therapeutics, Inc. (LRMR) Earnings
|
Expand Research on LRMR
| Next EPS Date | 11/5/26 | EPS Growth Rate | +41.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +7.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.36 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/4/26 |
Q226 | -$0.30 | -$0.38 | +$0.08 | N/A | N/A | N/A |  | | Details | |
| 5/14/26 |
Q126 | -$0.31 | -$0.53 | +$0.22 | N/A | N/A | N/A | | | Details | |
| 5/7/26 |
Q126 | N/A | -$0.53 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/19/26 | Q425 | -$0.73 | -$0.49 | -$0.24 | N/A | N/A | N/A | | | Details | |
| 3/18/26 |
Q425 | N/A | -$0.49 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/25 | Q225 | -$0.41 | -$0.48 | +$0.07 | N/A | N/A | N/A | | | Details |
